share_log

Illumina | 8-K: Current report

Illumina | 8-K: Current report

Illumina | 8-K：重大事件
美股SEC公告 ·  2024/11/05 05:12

Moomoo AI 已提取核心訊息

Illumina reported Q3 2024 core revenue of $1.1 billion, down 2% YoY, with GAAP operating margin at 68.6% and non-GAAP operating margin at 22.6%. The quarter saw GAAP diluted EPS of $4.03 and non-GAAP diluted EPS of $1.14, while generating strong free cash flow of $284 million.The company lowered its fiscal year 2024 core revenue guidance to decline ~3% YoY, with Q4 revenue expected at approximately $1.07 billion. However, Illumina raised its full-year non-GAAP operating margin guidance to 21-21.5% and non-GAAP diluted EPS guidance to $4.05-$4.15.Notable developments included the introduction of the MiSeq i100 Series sequencers, FDA approval for TSO Comprehensive companion diagnostics, and a favorable European Court of Justice ruling regarding GRAIL. The company also expanded its presence with a new global capability center in Bengaluru.
Illumina reported Q3 2024 core revenue of $1.1 billion, down 2% YoY, with GAAP operating margin at 68.6% and non-GAAP operating margin at 22.6%. The quarter saw GAAP diluted EPS of $4.03 and non-GAAP diluted EPS of $1.14, while generating strong free cash flow of $284 million.The company lowered its fiscal year 2024 core revenue guidance to decline ~3% YoY, with Q4 revenue expected at approximately $1.07 billion. However, Illumina raised its full-year non-GAAP operating margin guidance to 21-21.5% and non-GAAP diluted EPS guidance to $4.05-$4.15.Notable developments included the introduction of the MiSeq i100 Series sequencers, FDA approval for TSO Comprehensive companion diagnostics, and a favorable European Court of Justice ruling regarding GRAIL. The company also expanded its presence with a new global capability center in Bengaluru.
Illumina報告2024年第三季度核心營業收入爲11億美元，同比下降2%，GAAP營業利潤率爲68.6%，非GAAP營業利潤率爲22.6%。本季度GAAP攤薄後每股收益爲4.03美元，非GAAP攤薄後每股收益爲1.14美元，產生了強勁的自由現金流爲28400萬美元。該公司將2024財年的核心營業收入指引下調至同比下降約3%，第四季度營業收入預計爲約10.7億美元。然而，Illumina將全年非GAAP營業利潤率指引上調至21-21.5%，非GAAP攤薄後每股收益指引上調至4.05-4.15美元。值得注意的發展包括推出MiSeq I100系列測序儀、FDA批准電訊首科綜合伴隨診斷和歐洲法院對GRAIL的有利裁決。該公司還在班加羅爾擴展了其全球能力中心。
Illumina報告2024年第三季度核心營業收入爲11億美元，同比下降2%，GAAP營業利潤率爲68.6%，非GAAP營業利潤率爲22.6%。本季度GAAP攤薄後每股收益爲4.03美元，非GAAP攤薄後每股收益爲1.14美元，產生了強勁的自由現金流爲28400萬美元。該公司將2024財年的核心營業收入指引下調至同比下降約3%，第四季度營業收入預計爲約10.7億美元。然而，Illumina將全年非GAAP營業利潤率指引上調至21-21.5%，非GAAP攤薄後每股收益指引上調至4.05-4.15美元。值得注意的發展包括推出MiSeq I100系列測序儀、FDA批准電訊首科綜合伴隨診斷和歐洲法院對GRAIL的有利裁決。該公司還在班加羅爾擴展了其全球能力中心。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

獨立文件2  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    相關股票 相關股票
    代碼 迷你走勢 最新價
    Aspira Women's Health
    AWH
    -- 0.1868
    Fulgent Genetics
    FLGT
    -- 17.900
    紐爾真檢測
    NEOG
    -- 9.980
    XWELL Inc
    XWEL
    -- 1.0600
    NeoGenomics
    NEO
    -- 10.540
    解鎖完整榜單
    重估中國資產
    繼中國開創性的DeepSeek技術推出之後，華爾街大行重估對中國市場的投資前景。
    熱門討論
    特斯拉績後巨震，後市你怎麽看？
    特斯拉2024年Q4營收257.1億美元，同比增長2%，不及預期。Cybercab計劃2026年投產，預計車輛業務將於2025年恢復增長。面對特朗普回歸，特斯拉股價能否在2025年繼續攀升？
    TSLA收益預覽：猜測開盤價贏取獎勵！